BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8132740)

  • 1. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.
    Markowitz SD; Myeroff L; Cooper MJ; Traicoff J; Kochera M; Lutterbaugh J; Swiriduk M; Willson JK
    J Clin Invest; 1994 Mar; 93(3):1005-13. PubMed ID: 8132740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
    Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.
    Huang F; Hsu S; Yan Z; Winawer S; Friedman E
    Oncogene; 1994 Dec; 9(12):3701-6. PubMed ID: 7970729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium.
    Markowitz SD; Molkentin K; Gerbic C; Jackson J; Stellato T; Willson JK
    J Clin Invest; 1990 Jul; 86(1):356-62. PubMed ID: 2365825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
    Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
    Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of TGF-beta sensitivity in the VACO-411 human colon carcinoma line by somatic cell fusion with MCF-7.
    Traicoff JL; Periyasamy S; Brattain MG; Grady W; Casey G
    J Biomed Sci; 2003; 10(2):253-9. PubMed ID: 12595761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
    Manning AM; Williams AC; Game SM; Paraskeva C
    Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human polymeric immunoglobulin receptor (PIGR) 3'UTR and differential expression of PIGR mRNA during colon tumorigenesis.
    Traicoff JL; De Marchis L; Ginsburg BL; Zamora RE; Khattar NH; Blanch VJ; Plummer S; Bargo SA; Templeton DJ; Casey G; Kaetzel CS
    J Biomed Sci; 2003; 10(6 Pt 2):792-804. PubMed ID: 14631119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.
    Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C
    Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line.
    Wang CY; Eshleman JR; Willson JK; Markowitz S
    Cancer Res; 1995 Nov; 55(21):5101-5. PubMed ID: 7585558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes, suppressor genes, and allele losses in colon cancer.
    Yaremko ML; Wasylyshyn ML; Westbrook CA; Michelassi F
    Adv Surg; 1993; 26():323-32. PubMed ID: 8380308
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    Hsu S; Huang F; Friedman E
    J Cell Physiol; 1995 Nov; 165(2):239-45. PubMed ID: 7593201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas.
    Fazeli A; Steen RG; Dickinson SL; Bautista D; Dietrich WF; Bronson RT; Bresalier RS; Lander ES; Costa J; Weinberg RA
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10199-204. PubMed ID: 9294187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer.
    Friedman JB; Brunschwig EB; Platzer P; Wilson K; Markowitz SD
    Int J Cancer; 2004 Aug; 111(1):72-5. PubMed ID: 15185345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.
    Sevignani C; Wlodarski P; Kirillova J; Mercer WE; Danielson KG; Iozzo RV; Calabretta B
    J Clin Invest; 1998 Apr; 101(8):1572-80. PubMed ID: 9541486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
    Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
    Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.